TRIPS-Plus IP demands from EU could halt South American trade deal
This article was originally published in Scrip
Free trade negotiations between the EU and the Latin American trade bloc Mercosur (Argentina, Brazil, Paraguay and Uruguay) are at a standstill, in part at least because of demands from the EU that Mercosur introduce tougher measures to protect intellectual property rights. At a time when Brazil is endeavouring to become more self-sufficient in pharmaceutical production and Argentina is imposing bans on drug importation (scripintelligence.com, 6 June 2011), it is unsurprising that Mercosur opposes EU proposals for 5-year patent extension for drugs and 10-year data exclusivity.
You may also be interested in...
Public health advocates say that commercial concerns must take a back seat to health interests if COVID-19 technologies are to be made available to those who need them. But industry says that relaxing IP protections is not the solution and that many companies have already invested significant amounts of money in potential new treatments and vaccines.
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
Intellectual property rights are under the microscope as countries prepare to provide affordable and timely access to pandemic technologies.